<DOC>
	<DOCNO>NCT01113489</DOCNO>
	<brief_summary>Although well know presence uncontrolled inflammation upper airway may compromise control asthma may favor progression asthma toward severe grade disease , study address whether therapy aim control upper low airway inflammation may effective control asthma . Markers oxidative stress inflammation Nitrotyrosine IL-5 increase airway child atopic asthma correlate level oral nasal FeNO , grade atopy . We hypothesize treatment Beclometasone nebulized facial mask ( treat upper low airway ) able reduce production oxidant well IL5 district thus promote clinical functional improvement mild intermittent asthmatic child . The result provide study contribute clarify relationship nasal bronchial inflammation .</brief_summary>
	<brief_title>Assessment Oxidative Stress Markers Upper Lower Airways Atopic Children Treated With Nebulized Beclomethasone</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Beclomethasone</mesh_term>
	<criteria>child intermittent asthma allergic rhinitis child acute respiratory symptom last 4 week child nasal polyposis bronchial respiratory tract infection child severe exacerbation asthma result hospitalization last month</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>May 2010</verification_date>
</DOC>